RxDoctor Payments Data

Molly McCracken

Gerontology · Richmond, VANPI 1760835961

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2022 at $2,375 and has fallen 95.0% since, to $120 in 2025. Among gerontology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,117in general payments, 2019–2025

Across 276 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$654
  • Johnson & Johnson$582
  • Takeda Pharmaceuticals U.S.A., Inc.$419
  • QOL Medical, LLC$337
  • Bristol Myers Squibb$294
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$5,05699%
  • Education$611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,117 in reported general payments places this provider in the 90th percentile of 130 gerontology providers in Virginia.

See all gerontology providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide20$15,265
Tacrolimus16$11,673
Famotidine44$600
Prednisone105$457
Pantoprazole Sodium48$443
Hydralazine Hcl14$341
Omeprazole13$340
Doxazosin Mesylate13$246
Losartan Potassium19$199
Tamsulosin Hcl22$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,459$15,26520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 130 gerontology providers in Virginia.

Other gerontology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →